response

room

AMGEN Inc.

rating

FREE Trading Room via (Google Search)⟶  𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

product

3 other approved products, all growing revenue.

3 other approved products, all steady and growing revenue.

$AMGN $SPY  I love AMGEN 🔥🥂🚂 $SPY $QQQ _101

$SPY  I gotta be the luckiest dude ever today, only was short $MCD &amp; $AMGN the only 2 stocks red of my 100+ watchlist.

approval

Loyal $MNKD pre~R/S Longs like me: we’re 1 pediatric approval &amp; new CEO/ownership away from being a life changing juggernaut for patients.

Kroger Co.

executive

$KR these food company ceo&#39;s are failing.

price

They price gouge on items, then brag about profits while sales volume are down.

$KR ridiculous low low price Add to shares here

Prices continue to rise. https://bit.ly/3hCoqyD

#Seattle, for example, already has very high supermarket prices and customers there would be getting screwed do to lack of competition if such BO goes on.

I have a hard time understanding the deduction of $ACI dividend from $KR purchase price.

They need to figure out supply, not get rewarded and jack up prices for not doing there job.

$KR $ACI Food prices skyrocketing and these guys want to limit competition?

Albertson’s prices are waaay overpriced from my experience. $KR

vote

DON&#39;T VOTE FOR THE FRAUDULENT MERGER!

dividend

We have taken a stock hit for dividend not received.

joke

At the grocery store, a 30 pack of uncooked wings is $29  at Vons, no joke.

quot

&quot;My parents have worked there for the last 30 years. This will help me not only further my education,

With these increases in prescription drug usage, misuse of expired or unused medications is always a concern. &quot;Ralphs Pharmacy is beyond excited to once a (.  )

rise

$KR NEW ARTICLE : Kroger Stock Rises on Improved Full-Year Outlook https://www.stck.pro/news/KR/38388038

$KR (+3.5% pre) Kroger Stock Rises on Improved Full-Year Outlook

http://ooc.bz/l/114301

Kroger Stock Rises on Improved Full-Year Outlook  $KR $ACI $ACIW $AMZN $WMT 

https://newsfilter.io/a/245ff2cc54a8327e996e921a0c0c6fdb

We alerted the BUY signal at $46.71 and we were able to close this one with profit at $45.98 💖

$KR Bullish Call Spread at $0.74 Appears to be a Good Buy https://tinyurl.com/2ofdykfa

$KR super markets raking money in STRONG BUY here

$KR Buy Kroger because everyone must eat…even during a recession! 🥗🍗🥓🍱🥘🧆🍜🥞🥧🍓🍒🥑🍌🍎🍇🥦🥩🥖🥒🥕🥬🧅🫑🍽️

$KR  of the market wasn’t ab to drop off a cliff in December id say KR made a good buy

$ACI  basically it’s the equivalent of $KR saying they’re buying Albertsons for $34 / share in 2024 .. so -  a great buy ,

Madrigal Pharmaceuticals Inc

data

$CACO Perhaps the biggest kick in the nuts is seeing this garbage $MDGL hit all time highs yesterday at $315 after reporting NASH data.

$MDGL as good as the phase 3 data was this is fuckin nuts and the manipulation couldn&#39;t be more blatant.

Data is not even as good as some competitors

$MDGL So many irregularities with the data.

$MDGL if you look at the data closer, it is actually a disgused failure.

This market is a shit show that wants to collapse and any bad data this will get eviscerated!

The data is dropping with an 830am eastern time conference call.

Leaving data to last possible minute isn’t a good sign.

market

$MDGL this stock market is so full of shit.

$MDGL $VKTX markets going up and this aint.

Suddenly you realize the market is not as big as they are claiming!

$MDGL This is a perfect example of what is wrong with this market still.

show

$MDGL Today is going to be an absolute shit show likely with markets tanking and no news here.

strike

suck

$MDGL For all the mean and rude assholes out there.

WTF Jerry even the neighborhood asshole can be civil.

$MDGL down down down let’s go bears fuck this piece of crap

$MDGL a lot of options for tomorrow are being fucked with.

It still has room to go higher, much higher.

$MDGL first time buyers welcome .. lots of room above to go

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

I don’t have to wait for fda approval for such low MC like ETNB is good promising data in next 3 weeks .. it can 3x my investments .. like AKRO is seating at 2B… ETNB HAS a strong potential for 2-3x from here next 3-4 weeks

This is an outstanding setup for $VKTX&#39;s VK2809 P2b study which is scheduled to release data in Q2 2023.

Well for genius shorts who can&#39;t read medical data, this is a GREAT shorting opportunity.

$VKTX from what I&#39;ve read from the preliminary trial data, the molecule is good, maybe better than $MDGL and has applications in weightloss.

$MDGL $ALT $TERN will wind up better with much better data.

With slam-dunk efficacy data and two years worth of safety data with no significant adverse safety events reported, Resmetirom has a clear path forward to accelerated approval.

$MDGL their PhIII data are so resoundingly positive that this has been termed a “watershed moment” and a “shock win” for the company.

bull

$MDGL cheers bulls great finish to the year!

$MDGL congrats to all longs and bulls here.

$MDGL benefits of owning low float market king bull.

$MDGL  
The MM now  
ok guys we did a great job this week let&#39;s celebrate Christmas and enjoy the fool&#39;s bulls&#39; money

$MDGL The horns on this bull are massive.

$MDGL - Congrats bulls on MDGL&#39;s stellar P3 performance and strong price run especially leading up to the holidays.

trial

$MDGL this is the cream of the crop, we already have stellar phase 3 results in the books.

$MDGL nice opportunity to add a few hundred shares here 😆  the celebration of shorts today reminded me when the stock price dropped sharply by 27% in a couple of days before trial readout.

Based on my multi year knowledge in NASH field, mdgl management so far did the best execution of clinical development - too many things to exemplify here!

Study results showed statistically significant absolute reductions in hepatic fat fraction at week 13 with pegozafermin administered every week or every two weeks compared to placebo.

After reaching its endpoints on its Phase 3 data we have seen a $240 spike!

Plus, remember this company is light years ahead of its competitors none of whom have had success with Phase 3. Bullish!

$VKTX Truth: VKTX increased more than 100% last 3 days since $MDGL has Phase 3 results.

Top Stocks matching your search for "response room"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

AMGN

AMGEN Inc.

-3.69%

$241.87 - $232.95

Nov, 15, 2022

KR

Kroger Co.

8.52%

$44.27 - $48.04

Mar, 3, 2023

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Dec, 18, 2022

AMGN

AMGEN Inc.

-3.69%

$241.87 - $232.95

Nov, 15, 2022

KR

Kroger Co.

8.52%

$44.27 - $48.04

Mar, 3, 2023

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Dec, 18, 2022